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meals; at 4-h plasma TAG concentrations declined follow-
ing the IE fat but continued to rise following the non-IE fat. 
Insulin, glucose, paracetamol, PYY and GIP concentrations 
increased significantly after the test meals (time effect; 
P < 0.001 for all), but did not differ between test meals. 
Feelings of fullness were higher following the non-IE PSt/
PK meal (diet effect; P = 0.034). No other significant dif-
ferences were noted.
Conclusions Interesterification of PSt/PK increases early 
phase postprandial lipaemia (0–4 h); however, further 
investigation during the late postprandial phase (4–8 h) is 
warranted to determine the rate of return to baseline values.
Trial registration number Clinicaltrials.gov as NCT02365987.
Keywords Interesterified fat · Palm stearin · Palm kernel · 
Postprandial lipaemia
Introduction
The process of random interesterification is extensively 
used by the food industry to create fats with desirable 
functional characteristics for use in spreads and bakery 
products. This process avoids the use of trans fatty acids 
and results in a fat with a lower saturated fatty acid (SFA) 
content than traditional hard fats. Interesterification of fats, 
which may be carried out by random and directed, chemi-
cal or enzymatic processes, rearranges fatty acids on their 
glycerol moiety within the triacylglycerols (TAG) species, 
thereby changing their TAG structure [stereospecific (sn)-
positional composition] and their melting properties [1]. 
Randomly interesterified (IE) fat blends rich in palmitic 
acid (used in the European market) and stearic acid (used 
in the North American market) are most commonly used 
by food manufacturers, and current intakes are estimated to 
Abstract 
Purpose Interesterification of palm stearin and palm ker-
nal (PSt/PK) is widely used by the food industry to create 
fats with desirable functional characteristics for applica-
tions in spreads and bakery products, negating the need for 
trans fatty acids. Previous studies have reported reduced 
postprandial lipaemia, an independent risk factor for CVD, 
following interesterified (IE) palmitic and stearic acid-rich 
fats that are not currently widely used by the food indus-
try. The current study investigates the effect of the most 
commonly consumed PSt/PK IE blend on postprandial 
lipaemia.
Methods A randomised, controlled, crossover (1 week 
washout) double-blind design study (n = 12 healthy males, 
18–45 years), compared the postprandial (0–4 h) effects of 
meals containing 50 g fat [PSt/PK (80:20); IE vs. non-IE] 
on changes in plasma triacylglycerol (TAG), glucose, glu-
cose-dependent insulinotropic polypeptide (GIP), peptide 
YY (PYY), insulin, gastric emptying (paracetamol concen-
trations) and satiety (visual analogue scales).
Results The postprandial increase in plasma TAG was 
higher following the IE PSt/PK versus the non-IE PSt/
PK, with a 51 % greater incremental area under the curve 
[mean difference with 95 % CI 41 (23, 58) mmol/L min 
P = 0.001]. The pattern of lipaemia was different between 
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be 2–10 % of daily energy intake. However, despite their 
widespread use, there has been little research on the health 
effects of the most commonly consumed palmitic acid-rich 
IE fats.
The association between dietary fatty acids and cardio-
vascular disease (CVD) risk has been extensively studied, 
and predictive equations on their blood lipid effects have 
been validated [2]. However, whilst the total fatty acid 
composition of IE fats is identical to their non-IE fat, the 
sn-positional composition and physical characteristics are 
different, making direct comparisons to non-IE fats inva-
lid. Indeed, it is believed that differences in sn-positional 
composition between some animal and plant fats may 
explain their divergent effects on atherogenicity despite 
similar fatty acid compositions. SFA is mainly present in 
the sn-1 and sn-3 positions of TAG molecules in vegetable 
oils, but in animal fats, they are predominantly in the sn-2 
position. Random interesterification of vegetable oils there-
fore increases the proportion of SFA in the sn-2 position. 
Animal studies have demonstrated that consumption of 
TAG-containing palmitic acid in the sn-2 position promotes 
atherogenesis to a greater extent than TAG-containing pal-
mitic acid in the sn-1 or sn-3 positions [3–5]. However, 
human dietary intervention studies have not demonstrated 
that there are any chronic effects of sn-positional compo-
sition or interesterification of palmitic acid-rich plant fats 
(whereby the proportion of palmitic acid in the sn-2 posi-
tion is increased) on blood lipids or insulin sensitivity [6–
10]. Previous research from our group and others on the 
acute effects of IE palmitic acid-rich fats (palm oil/olein) 
consistently shows that IE fats reduce postprandial lipaemia 
[11–14], in addition to a concurrent reduction in incretin 
gut hormone responses [15] but do not influence postpran-
dial glucose and insulin concentrations, when compared to 
the non-IE fat equivalent or a control oil. However, these 
previously studied fats have little commercial or health rel-
evance, as they are rarely used as an ingredient by the food 
industry because they do not possess suitable functional 
properties. The most commonly used IE fats in commer-
cially available foods are blends of plant oils/plant oil frac-
tions, whereas single fat sources, such as palm oil or palm 
olein oils, are rarely included in industrially processed 
foods. Blends of palmitic acid- and lauric acid-rich IE fats 
are the most commonly used IE fats in the European food 
industry. These fats are generally derived from palm fruits 
and include palm oil fractions such as palm stearin (PSt) 
(high in palmitic acid) and, in smaller proportions, palm 
kernel oil (PK) or coconut oil (both rich in lauric acid). The 
most commonly consumed IE fat in Europe consists of a 
blend of IE PSt/PK (typically 80:20) to create a ‘hardstock’ 
which is blended with vegetable oils (rapeseed or linseed) 
in varying amounts to create the desired functionality, 
depending upon the application.
It is now well known that an elevated non-fasting TAG 
(postprandial) concentration is an important risk fac-
tor for both CVD and other chronic metabolic conditions 
such as fatty liver, insulin resistance and type 2 diabetes. 
Three large prospective cohort studies have established 
non-fasting TAG as a significant predictor of CVD risk 
[16–18]. The mechanisms linking postprandial lipaemia to 
risk of atherosclerotic CVD underpin many of the observed 
chronic effects of dietary fats on CVD risk, including 
effects on lipoprotein remodelling, oxidative stress, inflam-
mation and endothelial dysfunction [19]. Although we 
spend most of our day in the postprandial state (~18 h), 
most studies investigating the effects of dietary fat on CVD 
risk markers have focused on fasting lipid profiles. There-
fore, determining an individual’s postprandial response to 
different dietary fats is an important tool for predicting car-
dio-metabolic risk and understanding their chronic effects.
The primary aim of the current study was therefore to 
investigate the effect of one of the most commonly con-
sumed IE fat blends on postprandial lipaemia. To gain a 
better understanding of why IE fats elicit differences in 
lipaemia, a secondary aim was to investigate the effects on 
incretin gut hormones, satiety, gastric emptying, glucose 
and insulin concentrations. It is hypothesised that IE PSt/
PK will reduce the postprandial lipaemic response com-
pared to non-IE PSt/K and that this may be related to a 
delay in gastric emptying with subsequent effects on sati-
ety, glycaemia and incretin hormones.
Materials and methods
Participants
Ethical approval for the study was obtained from the 
Research Ethics Committee of King’s College London 
(CREC BDM/14/15-26), and written informed consent 
was provided by participants. The study was conducted 
in accordance with the ethical standards laid down in 
the 1964 Declaration of Helsinki and its later amend-
ments. The trial was registered at clinicaltrials.gov as 
NCT02365987. Healthy adult males (aged 18–45 years) 
were recruited via advertisements and circular emails 
within King’s College London which commenced in Feb-
ruary 2015 and completed in April 2015. The participants 
attended a screening visit at the Metabolic Research Unit 
(MRU) at the Diabetes and Nutritional Sciences Division, 
King’s College London following an overnight fast. Their 
weight, height, waist circumference, percentage body fat, 
seated blood pressure, haematology, glucose, insulin, liver 
function and lipid profile were measured. Participants were 
requested to complete a 3-day diet diary to assess their 
habitual nutritional intakes using Nutritics Ltd, Ireland. 
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Exclusion criteria were as follows: medical history of 
myocardial infarction, angina, thrombosis, stroke, cancer, 
liver or bowel disease or diabetes, body mass index <18 
or >35 kg/m2, plasma cholesterol ≥7.5 mmol/L, plasma 
TAG >3 mmol/L, plasma glucose >7 mmol/L, blood pres-
sure ≥160/100 mmHg, current use of antihypertensive 
or lipid lowering medications, alcohol intake exceeding 
a moderate intake (>28 units/week) and current cigarette 
smoker. Sample size calculations were based on 10 par-
ticipants completing at 90 % power, P < 0.05 to detect a 
0.54 mmol/L difference in peak plasma TAG concentra-
tions with a SD of differences of 0.5 mmol/L using data 
from Sanders et al. [12].
Study design
A randomised, double-blind, crossover design was used to 
compare two test meals, with a minimum 1-week washout 
period. Each test meal consisted of a muffin, custard (Birds 
Eye, Premier Foods, UK) and a milkshake and provided 
3.5 MJ (832 kcal), 15 g protein (7 % E), 81 g carbohydrate 
(37 % E), 52 g (50 g from test fat) fat (56 % E) and 1.5 g 
non-effervescent paracetamol. The paracetamol was added 
to measure rates of gastric emptying [20]. The muffin was 
cut into small bite-sized chunks and evenly covered with 
the custard mix into which the paracetamol had been dis-
solved. The test fats were: non-IE PSt/PK and IE PSt/PK 
blended at a ratio of 80:20 PSt/PK, made from the same 
batch of oil (Archer Daniels Mills, Erith, UK). Both fat 
blends had a similar fatty acid composition, but the propor-
tions of palmitic acid at the sn-2 position were 36 mol% in 
non-IE PSt/PK and 55 mol% in IE PSt/PK (Table 1). Meas-
urement of the solid fat content by NMR [European labora-
tories of Archer Daniel Mills (Hamburg Germany)] of non-
IE PSt/PK and IE PSt/PK gave values of 55 and 62 % at 
20 °C, 33 and 34 % at 30 °C, 24 and 21 % at 35 °C and 17 
and 11 % at 40 °C, respectively.
The allocation of treatment was blinded from both the 
investigators and the study participants. On the day preced-
ing each test meal, participants were told not to participate 
in strenuous exercise and to avoid alcohol, caffeine and 
foods high in fat. They were provided with a standardised 
low fat meal (2–3 MJ containing <10 g fat) to consume 
as their evening meal, which they were required to con-
sume before 22:00 h and then to avoid eating or drinking 
anything, except water. Participants attended the MRU 
between 08:00 and 10:00 h the following morning. A can-
nula was inserted into the forearm (antecubital vein), and 
the test meal was consumed within 10 min. Further venous 
blood samples were collected regularly until 4 h follow-
ing the test meal. Participants had access to water to sip as 
required over the 4 h. Visual analogue scales (VAS) were 
completed by participants at fasting and 30-min intervals 
postprandially to measure appetite; ‘how hungry do you 
feel?’; ‘how strong is your desire to eat?’; and ‘how full 
do you feel?’. Following the 4 h blood sample, they were 
given an ad libitum lunch meal which was selected from 
their second preference from a choice of three meals. Each 
meal contained 3000 kcal (1.25 mJ) and matching macro-
nutrient profiles (48 % carbohydrate, 19 % protein and 
28 % fat) and energy density (approximately 1.6 kcal/g). 
Participants ate until they were full, and the meals were 
weighed before and after eating.
Analytical methods
Test oils were analysed for their fatty acid composition 
and the sn-2 fatty acid composition. The fatty acid com-
position of the oil and the test oil TAG-derived 2-mono-
acylglycerol (2-MAG) were analysed following HCl-
catalysed methylation to form methyl esters by capillary 
gas liquid chromatography (GLC) using a BP75 column 
(25 m × 220 µm × 0.25 µm; SGE Analytical Science, 
VIC, Australia) on an Agilent 6890 (Agilent Technologies, 
Cheshire, UK). Fatty acid methyl standards were obtained 
from Sigma (Poole, Dorset). The proportions of fatty acids 
in the sn-2 position of the TAG were determined follow-
ing incubation of the TAG with porcine lipase (Type VI-S, 
from porcine pancreas, EC 3.1.1.3, 100,000 units, Sigma, 
Poole, Dorset, UK), separation of the 2-MAG and analysis 
of its fatty acid composition [13].
Table 1  Fatty acid composition of the experimental fats (total) and 
the proportions of fatty acids in the sn-2 position of the dietary tria-
cylglyerols (mol%)
Fatty acid Non-IE PSt/PK IE PSt/PK
12:0
 Total 6.8 6.5
 sn-2 12.7 12.7
14:0
 Total 4.0 4.4
 sn-2 4.9 5.3
16:0
 Total 52.1 51.9
 sn-2 36.0 54.7
18:0
 Total 4.7 4.9
 sn-2 1.4 3.7
18:1n-9
 Total 26.5 26.3
 sn-2 36.9 19.6
18:2n-6
 Total 5.1 5.2
 sn-2 8.2 4.0
 Eur J Nutr
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Blood samples for TAG and insulin were collected into 
serum separator tubes and allowed to stand at room temper-
ature for 15 min, then centrifuged, and serum collected and 
stored frozen at −40 °C until analysis. Samples for plasma 
glucose concentrations were collected into fluoride oxa-
late vacutainers and kept on ice for a maximum of 15 min, 
before being centrifuged. Enzymatic assays were used to 
determine concentrations of TAG and glucose concentra-
tions (ILAB, Instrumentation Laboratories, Warrington, 
Cheshire, UK) using the GPO-PAP assay and GOD-PAP 
assay, respectively (Roche Diagnostics Limited, UK), on an 
ILAB-650 analyzer. Samples for glucose-dependent insuli-
notropic polypeptide (GIP) and peptide YY (PYY) analy-
sis were collected into 4 mL EDTA vacutainers containing 
100 μL of trasylol (10,000 KIU/mL, Nordic Pharma Ltd, 
Reading, UK) and kept on ice up to 15 min, followed by 
centrifugation and plasma storage at −80 °C until ana-
lysed using a sandwich ELISA and a radioimmunoassay kit 
(Linco Research, MO, USA), respectively, at Kings Col-
lege Hospital (KCH). Insulin concentrations were analysed 
on the Immulite 2000 analyser using the Siemans Advia 
Centaur two-site sandwich immunoassay (Siemans Medi-
cal Solution Diagnostics Europe Ltd, UK) at KCH. Par-
acetamol concentrations were analysed in serum samples 
using enzymatic assay on the ADIVA 2400 at KCH.
Statistical analysis
The data were analysed using SPSS version 20.0 (SPSS 
Inc, Chicago, IL, USA). For all tests, the significance level 
was set at P < 0.05 (two tailed). All data were normally dis-
tributed; they are expressed as mean ± SD or with 95 % 
CI. Incremental area under the curves (iAUC) was calcu-
lated with GraphPad Prism (version 5.01; GraphPad, La 
Jolla, CA 9203, USA) using the trapezoid rule. Statistical 
analysis of the data was carried out with repeated-measures 
analysis of variance, with meal and time as within-subject 
factors. Post hoc analyses were made using a Bonferroni 
correction.
Results
A total of 12 participants completed the study, their details 
are shown in Table 2. The flow of participants through the 
study is shown in online supplementary material (Supple-
mentary Figure 1).
Postprandial serum TAG concentrations (Fig. 1) were 
significantly lower following non-IE compared with 
IE (meal effect P = 0.009 and meal × time interaction 
P = 0.002) fat blends. Plasma TAG concentration peaked at 
3 h following the IE fat and continued to increase at 4 h fol-
lowing the non-IE fat, whereas plasma TAG concentrations 
started to decline at 4 h following the IE fat. Following 
non-IE, plasma concentrations were 0.43 mmol/L (95 % CI 
of the mean difference 0.21, 0.65) lower at 3 h compared 
with IE (P = 0.03). The iAUC for plasma TAG was 51 % 
(95 % CI 28, 75) lower (P = 0.001) following the non-IE 
blend [31 mmol/L min (95 % CI 16, 46)] versus the IE 
blend [72 mmol/L min (95 % CI 50, 94)]. Plasma concen-
trations of the major fatty acid constituents of the test meals 
(palmitic and oleic acid) did not differ between meals (data 
not shown). Plasma palmitic acid followed a similar pattern 
of response to plasma TAG reaching peak concentrations 
at 3 h following the IE fat (of 1.4 mmol/L; 95 % CI 1.0, 
1.8) and 4 h following the non-IE fat (of 1.2 mmol/L; 95 % 
CI 1.0, 1.45), but the iAUC was not significantly different 
between fats.
There were no significant differences in the pattern 
of the glucose or insulin responses (Fig. 2a, b) between 
test fats and no differences in the iAUC’s. Serum glucose 
Table 2  Characteristics of the 12 male subjects
a Fasting blood samples
Mean values ± SD
Age (year) 20.5 ± 1.1
BMI (kg/m2) 22.4 ± 2.8
Serum total cholesterol (mmol/L)a 3.7 ± 0.4
Serum HDL cholesterol (mmol/L)a 1.3 ± 0.3
Serum LDL cholesterol (mmol/L)a 2.0 ± 0.4
Serum triacylglycerol (mmol/L)a 0.9 ± 0.4
Glucose (mmol/L)a 5.1 ± 0.4
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Fig. 1  Mean change in plasma triacylglycerol (TAG) and 95 % CIs 
in healthy men (n = 12) after test meals containing 50 g experimental 
fat from non-IE PSt/PK (open circles) and IE PSt/PK (filled circles). 
Deviations from fasting values were analysed by ANOVA, with the 
two meals and time (0–240 min) as factors: meal × time interaction 
P = 0.002; meal effect P = 0.009
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concentrations increased significantly following the non-
IE and IE fat above fasting levels (5.44 and 5.47 mmol/L, 
respectively) at 30 min (7.26 and 7.06 mmol/L, respec-
tively) and returned to baseline values at 60 min (time 
effect P < 0.001). Insulin concentrations increased sig-
nificantly following the non-IE and IE fat above fasting 
levels (8.4 and 10.1 mIU/L, respectively) reaching peak 
concentrations at 30 min (110.0 and 115.0 mmol/L, respec-
tively); time effect P < 0.001. PYY and GIP concentra-
tions (Table 3) increased postprandially following both test 
meals (time effect P < 0.001 for both), but there were no 
significant differences between test meals. Paracetamol 
concentrations (Table 3) increased significantly follow-
ing both test meals (time effect P < 0001) but did not dif-
fer between meals; iAUC non-IE 1678 mg/L min (95 % CI 
1517, 1838) and IE 1656 mg/L min (95 % CI 1470, 1843).
VAS satiety measurements showed a significant time 
effect for all (P < 0.001 for all), Fig. 3a–c. There was a 
significant diet effect (P = 0.034) for change from baseline 
in Fullness (‘How full do you feel’), with a higher fullness 
after the non-IE meal. There were no differences between 
meals for Hunger (‘How hungry do you feel’) or Desire to 
eat (‘How strong is your desire to eat’). The total energy 
intake and weight of food consumed after the ad libitum 
meals were similar following both test fats; IE 877 kcal 
(95 % CI 646, 1109); 546 g (95 % CI 402, 690) and non-IE 
1028 kcal (95 % CI 726, 1330), 636 g (95 % CI 456, 816).
Discussion
The primary aim of this study was to investigate the acute 
effects of one of the most commonly used IE palmitic 
acid-rich fat blends versus its non-IE counterpart on post-
prandial lipaemia in order to investigate whether interest-
erification of the fats that are commercially available might 
influence cardiovascular risk. Contrary to our hypothesis, 
we observed a significantly higher postprandial lipaemia 
following the IE palmitic acid-rich fat. Previous work by 
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Fig. 2  Mean change in serum a glucose and b insulin concentrations 
and 95 % CIs in healthy men (n = 12) after test meals containing 
50 g experimental fat from non-IE PSt/PK (open circles) and IE PSt/
PK (filled circles). Deviations from fasting values were analysed by 
ANOVA, with the two meals and time (0–240 min) as factors: time 
effects for both P < 0.001
Table 3  Plasma PYY (ng/L), GIP (ng/L) and paracetamol (mg/L) 
concentrations following consumption of interesterified and non-
interesterified fat blends (0–240 min)
Values are means with 95 % CI
a Deviations from fasting values were analysed by ANOVA, with 
meal type and time as within-subject factors. Time effect for all 
measures P < 0.001
Time (min)a Non-IE PSt/K IE PSt/PK
GIP
 0 51 (20, 83) 35 (26, 45)
 30 265 (212, 318) 241 (186, 296)
 60 283 (212, 354) 260 (207, 134)
 120 299 (246, 352) 309 (243, 375)
 180 281 (208, 354) 341 (245, 384)
 240 201 (160, 242) 208 (155, 261)
PYY
 0 107 (92, 121) 104 (81, 127)
 30 122 (110, 134) 134 (110, 159)
 60 135 (123, 148) 139 (113, 165)
 120 130 (114, 146) 124 (105, 142)
 180 124 (112, 136) 124 (110, 138)
 240 132 (121, 144) 121 (112, 131)
Paracetamol
 0 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
 30 3.8 (3.1, 4.6) 4.3 (3.6, 5.1)
 60 7.0 (5.9, 8.1) 6.8 (5.6, 7.9)
 120 9.8 (8.7, 10.8) 9.7 (8.4, 11.0)
 180 8.1 (7.4, 8.8) 7.8 (6.6, 8.9)
 240 5.9 (5.1, 6.7) 5.9 (5.0, 6.9)
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our group [11–13] and others [14] has consistently reported 
a significantly lower (or non-significant lower) postpran-
dial lipaemia following IE palm oil/palm olein versus the 
non-IE counterpart or a control oil. A possible explanation 
arises upon examination of the solid fat content and the sn-
positional composition of the test fats which change fol-
lowing the process of interesterification. In previous stud-
ies, single fat sources (palm oil/olein) were interesterified 
resulting in a higher proportion of palmitic acid in the sn-2 
position and a higher solid fat content. For example, non-
IE palm olein and IE palm olein have a solid fat content at 
37 °C of 4 and 15 %, respectively, and % of palmitic acid 
in the sn-2 position of 7 and 37 %, respectively [13]. How-
ever, in the current study, a blend of two fats was interester-
ified; palm stearin (PSt) and palm kernel (PK) (80:20). The 
non-IE PSt/PK and the IE PSt/PK had a solid fat content 
at 35 °C of 24 and 21 %, respectively, and % of palmitic 
acid in the sn-2 position of 36 and 54 %, respectively. Thus, 
interesterification of both palm olein (not commonly con-
sumed) and PSt/PK (widely consumed) fats increased the 
proportion of palmitic acid in the sn-2 position, but only 
interesterification of palm olein increased the solid fat con-
tent at 35–37 °C. In fact, interesterification of the PSt/PK 
blend slightly reduced the solid fat content at 35 °C. These 
differences in solid fat are likely to arise from differences 
in the proportion of tri-palmitin (PPP); for example, non-
IE PSt contains approximately 28 % of its TAG species as 
PPP, which decreases upon interesterification [21], whilst 
the interesterification of palm olein increases the propor-
tion of PPP from 1 to 8 % [12]. This would also explain 
the lack of effect of sn-positional composition on postpran-
dial lipaemia observed by Summers et al. [22] and Zampe-
las et al. [23], when test fats containing single low melting 
point TAG species are fed; 1, 3-oleyl, 2-palmityl (OPO) 
versus 1, 2-palmityl, 3-oleyl (POO). Our results therefore 
add to the growing body of evidence that the proportion 
of solid fat content at 37 °C is a major determinant of the 
postprandial response, rather than the sn-positional compo-
sition [1].
It was hypothesised that a high solid fat content may 
attenuate the postprandial response via effects on rates of 
gastric emptying which may subsequently influence gly-
caemic, incretin and satiety responses to the meal. Previ-
ously, gastric emptying measured using scintigraphy has 
been shown to be delayed following consumption of solid 
fats (hydrogenated vegetable oil; melting point 43 °C) com-
pared to liquid oils (vegetable oil) in healthy volunteers, 
with the time to emptying 90 % fat/oil following the liquid 
oil and solid fat at 206 and 264 min, respectively [24]. It 
is plausible that the solid fat content of the test fats may 
influence the lipaemic response by effects on coalescence, 
phase separation and micelle formation and/or access of 
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Fig. 3  Mean change in VAS satiety scores (cm) with SEM, n = 12 
after test meals containing 50 g experimental fat from non-IE PSt/
PK (open circles) and IE PSt/PK (filled circles). Deviations from fast-
ing values were analysed by ANOVA, with the two meals and time 
(0–240 min) as factors. a Fullness; time effect P < 0.001; diet effect 
P = 0.034. b Hunger; time effect P < 0.001. c Desire to eat; time 
effect P < 0.001
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digestive enzymes to the fat droplets (due to differences in 
particle size) thus delaying gastric emptying and attenuat-
ing the postprandial lipaemic response. However, contrary 
to our hypothesis, there were no differences in estimated 
rates of gastric emptying indirectly assessed by paraceta-
mol absorption, despite large differences in lipaemia. This 
would provide a likely explanation for the lack of differ-
ence observed in the glycaemic and gut hormone response, 
which indicate similar rates of delivery of glucose and fat 
to the intestine, and similar levels of gastric distention and 
incretin release. These results concur with current evi-
dence that interesterification of palmitic acid-rich fats does 
not adversely affect acute changes in glucose or insulin 
responses [13–15, 23].
Despite the lack of differences in incretin responses and 
gastric emptying, the VAS scores showed that the non-IE 
fat resulted in a significantly greater feeling of fullness 
compared to the IE fat. It is plausible that the higher solid 
fat content of the non-IE fat may have increased gastric dis-
tention due to the retention of the higher melting point TAG 
species which would stimulate a greater feeling of fullness 
[25], but this is not supported by the gastric emptying data, 
or the other VAS scores and requires further investigation.
In the absence of differences in gastric emptying 
between the test meals, it is possible that the differences 
in lipaemia were influenced by differences in enzymatic 
hydrolysis and removal of TAG and remnant particles 
from the circulation, which are also known to influence 
the rate and extent of lipaemia, independent of effects on 
gastric emptying. It had previously been reported in animal 
and infant studies that SFA in the sn-2 position enhances 
absorption [26] and delays hydrolysis of TAG by lipopro-
tein lipase (LPL) [27], suggesting that IE palmitic acid-rich 
fats (with an increased proportion of sn-2 palmitic acid) 
may be absorbed more rapidly and cleared more slowly 
from the circulation and enhance the postprandial response. 
However, Summers reported no arterio-venous differences 
across adipose tissue following fats with palmitic acid pre-
dominantly in the sn-2 position versus the sn-1 and -3 posi-
tions [22], suggesting that there is no effect of sn-positional 
composition on LPL activity and release of fatty acids into 
venous plasma or storage in adipocytes. Indeed, we have 
previously reported no difference in post-heparin lipopro-
tein and hepatic lipase activity following palmitic acid-rich 
fats versus a control oil, with different solid fat contents, 
despite differences in postprandial lipaemic response [13]. 
Whilst it would be of interest to measure rates of hydrolysis 
by lipoprotein lipase and pancreatic lipase (in vitro using 
simulated gastric models), it was beyond the scope of this 
study.
The current trial was planned as an exploratory inves-
tigation into postprandial lipaemic responses to these 
never-before studied commercially available fats. The 
study design has limitations, including the method used 
to measure gastric emptying. Measurement of the absorp-
tion of paracetamol following a 1.5-g oral load was used 
in the current study as it is a relatively simple and inex-
pensive method and has been shown to correlate with the 
‘gold standard technique’ of scintigraphy [28]. However, 
paracetamol is water-soluble and therefore empties with 
aqueous components in the meal, and consequently any dif-
ferences in the amount of solid fat retained in the stomach 
between meals might not be revealed using this method 
[29]. Another key limitation is that postprandial measure-
ments were only made up to 4 h. It is possible that although 
the IE fat caused a rapid increase in lipaemia (peaking at 
3 h), it might have returned to fasting values at a differ-
ent rate to the non-IE fat (as suggested by the decline it 
TAG concentrations at 4 h following the IE fat). Although 
there is robust epidemiological evidence for the relation-
ship between elevated non-fasting TAG and risk of CVD 
[16–18], it remains uncertain as to whether the duration 
of lipaemia (time to return to baseline) or the peak TAG 
(Cmax) response has a greater impact on subsequent risk of 
CVD [via effects on postprandial inflammation, oxidative 
stress, impaired vascular function and lipoprotein remod-
elling (small dense LDL, reduction in HDL concentration 
and cholesterol rich remnant particles)]. Despite its limited 
duration, the current study shows a 0.43-mmol/L differ-
ence in 3 h plasma TAG concentrations which is consid-
ered a clinically relevant difference; previous prospective 
cohort studies have observed significant differences in 
hazard ratios (multivariable adjusted) for CVD mortality 
[18], CVD events [16] and IHD [17] between quintiles of 
non-fasting TAG (differences in quintiles of approximately 
0.3 mmol/L) in the postprandial range of TAG observed 
in this study. Therefore, the difference in postprandial 
TAG concentrations following IE PSt/PK requires further 
exploration over a longer postprandial period to determine 
associations with acute cardio-metabolic risk markers and 
to elucidate the underlying mechanisms causing the differ-
ences in lipaemic response between IE and non-IE fats. It 
is also worth taking into consideration that the fatty acid 
composition of the background diet can influence the post-
prandial lipaemic response to standard test meals [30, 31]. 
Therefore, outcomes of single test meal studies of dietary 
fatty acids may not necessarily be extrapolated to effects 
of chronic intake since lack of equilibration between tis-
sue fatty acid pools reduces the chance of detecting effects 
of specific fatty acids and specific structural changes on 
postprandial CVD risk markers [32]. Lastly, it is also note-
worthy that this study was conducted on young healthy 
males. It is well known that different populations exhibit 
differences in postprandial lipaemic responses; for example 
sex, obesity, age, fasting TAG and insulin sensitivity influ-
ence the postprandial response to a standard test meal [19]. 
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Further research is therefore needed to evaluate the acute 
effects of IE fats in different population groups that are 
susceptible to elevated or prolonged postprandial lipaemic 
responses.
In conclusion, results from the current study show that 
a commercially relevant IE palmitic acid-rich fat used 
in many food applications throughout Europe results in 
a significantly higher early phase postprandial lipaemic 
response compared to its non-IE counterpart. Since ele-
vated non-fasting TAG is associated with an increased risk 
of CVD, and these IE fat blends are estimated to supply 
between 2 and 10 % of average daily energy intake, there 
is a pressing need to characterise their metabolic effects 
and investigate whether there is any impact on long-term 
cardio-metabolic health.
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